HK1110211A1 - - Google Patents
Info
- Publication number
- HK1110211A1 HK1110211A1 HK08101077.6A HK08101077A HK1110211A1 HK 1110211 A1 HK1110211 A1 HK 1110211A1 HK 08101077 A HK08101077 A HK 08101077A HK 1110211 A1 HK1110211 A1 HK 1110211A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- disease
- compound
- parkinson
- treatment
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0504103.3A GB0504103D0 (en) | 2005-02-28 | 2005-02-28 | Novel method |
PCT/GB2006/000684 WO2006090177A1 (fr) | 2005-02-28 | 2006-02-27 | Utilisation de 2-(2-nitro-4-trifluorométhylbenzoyl)-1,3- cyclohexanedione dans le traitement de la maladie de parkinson |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1110211A1 true HK1110211A1 (fr) | 2008-07-11 |
Family
ID=34430351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08101077.6A HK1110211A1 (fr) | 2005-02-28 | 2008-01-28 |
Country Status (18)
Country | Link |
---|---|
US (1) | US20090326072A1 (fr) |
EP (1) | EP1853241B1 (fr) |
JP (1) | JP2008531665A (fr) |
CN (1) | CN101163466B (fr) |
AT (1) | ATE524171T1 (fr) |
AU (1) | AU2006217650B2 (fr) |
BR (1) | BRPI0609177A2 (fr) |
CA (1) | CA2598517A1 (fr) |
DK (1) | DK1853241T3 (fr) |
ES (1) | ES2374761T3 (fr) |
GB (1) | GB0504103D0 (fr) |
HK (1) | HK1110211A1 (fr) |
IL (1) | IL185410A0 (fr) |
MX (1) | MX2007010480A (fr) |
PT (1) | PT1853241E (fr) |
RU (1) | RU2420272C2 (fr) |
WO (1) | WO2006090177A1 (fr) |
ZA (1) | ZA200707486B (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2010002258A (es) | 2007-08-27 | 2010-04-22 | Helicon Therapeutics Inc | Compuestos terapeuticos de isoxazol. |
JP2011507910A (ja) | 2007-12-21 | 2011-03-10 | ユニバーシティー オブ ロチェスター | 真核生物の寿命を変更するための方法 |
MX2011004769A (es) * | 2008-11-06 | 2011-11-29 | Biotie Therapies Inc | Tratamiento de sindrome de pierna sin reposo y alteraciones del sueño. |
EP2723320B1 (fr) | 2011-06-23 | 2016-01-13 | Swedish Orphan Biovitrum International AB | Composition pharmaceutique liquide comprenant de la nitisinone |
CN103622942A (zh) * | 2013-11-04 | 2014-03-12 | 江苏大学 | 左旋多巴/卡比多巴复方缓释混悬剂及其制备方法 |
ITUB20160650A1 (it) | 2016-02-11 | 2017-08-11 | Dipharma S A | Formulazioni farmaceutiche solide stabili contenenti 2-(2-nitro-4-trifluorometilbenzoil)-1,3-cicloesandione |
US9783485B1 (en) | 2016-11-30 | 2017-10-10 | Dipharma S.A. | Crystalline inhibitor of 4-hydroxyphenylpyruvate dioxygenase, and a process of synthesis and crystallization thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4780127A (en) * | 1982-03-25 | 1988-10-25 | Stauffer Chemical Company | Certain 2-(substituted benzoyl)-1,3-cyclohexanediones and their use as herbicides |
US5092919A (en) * | 1991-01-15 | 1992-03-03 | Imperial Chemical Industries Plc | Certain 2-(2'-methyl-3',4'-trisubstituted benzoyl)-1,3-cyclohexanediones |
FR2777781B1 (fr) * | 1998-04-24 | 2004-04-09 | Rhone Poulenc Rorer Sa | Associations riluzole et l-dopa pour le traitement de la maladie de parkinson |
US20050288187A1 (en) * | 2002-07-03 | 2005-12-29 | Hanauske-Abel Hartmut M | Inhibitor development for 4-hydroxyphenylpyruvate dioxygenase, employing tyrosinemia 1 as a model for human diseases mediated by 2-oxoacid utilizing dioxygenases |
WO2005007096A2 (fr) * | 2003-07-11 | 2005-01-27 | Merck & Co., Inc. | Traitement de troubles du mouvement au moyen d'un modulateur allosterique positif du recepteur du glutamate metabotropique 4 |
JP2010501532A (ja) * | 2006-08-18 | 2010-01-21 | シンジェンタ リミテッド | うつ病、および/または常習性薬物の使用に伴う禁断症状の治療のための、hppd阻害薬の使用 |
MX2011004769A (es) * | 2008-11-06 | 2011-11-29 | Biotie Therapies Inc | Tratamiento de sindrome de pierna sin reposo y alteraciones del sueño. |
-
2005
- 2005-02-28 GB GBGB0504103.3A patent/GB0504103D0/en not_active Ceased
-
2006
- 2006-02-27 RU RU2007131934/15A patent/RU2420272C2/ru not_active IP Right Cessation
- 2006-02-27 CN CN2006800133878A patent/CN101163466B/zh not_active Expired - Fee Related
- 2006-02-27 DK DK06709910.1T patent/DK1853241T3/da active
- 2006-02-27 CA CA002598517A patent/CA2598517A1/fr not_active Abandoned
- 2006-02-27 US US12/090,645 patent/US20090326072A1/en not_active Abandoned
- 2006-02-27 AT AT06709910T patent/ATE524171T1/de active
- 2006-02-27 WO PCT/GB2006/000684 patent/WO2006090177A1/fr active Application Filing
- 2006-02-27 PT PT06709910T patent/PT1853241E/pt unknown
- 2006-02-27 JP JP2007557572A patent/JP2008531665A/ja active Pending
- 2006-02-27 EP EP06709910A patent/EP1853241B1/fr active Active
- 2006-02-27 MX MX2007010480A patent/MX2007010480A/es not_active Application Discontinuation
- 2006-02-27 AU AU2006217650A patent/AU2006217650B2/en not_active Ceased
- 2006-02-27 BR BRPI0609177-6A patent/BRPI0609177A2/pt not_active IP Right Cessation
- 2006-02-27 ZA ZA200707486A patent/ZA200707486B/xx unknown
- 2006-02-27 ES ES06709910T patent/ES2374761T3/es active Active
-
2007
- 2007-08-21 IL IL185410A patent/IL185410A0/en unknown
-
2008
- 2008-01-28 HK HK08101077.6A patent/HK1110211A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
BRPI0609177A2 (pt) | 2010-02-23 |
WO2006090177A1 (fr) | 2006-08-31 |
MX2007010480A (es) | 2008-02-07 |
EP1853241B1 (fr) | 2011-09-14 |
EP1853241A1 (fr) | 2007-11-14 |
JP2008531665A (ja) | 2008-08-14 |
CA2598517A1 (fr) | 2006-08-31 |
US20090326072A1 (en) | 2009-12-31 |
RU2420272C2 (ru) | 2011-06-10 |
CN101163466A (zh) | 2008-04-16 |
IL185410A0 (en) | 2008-08-07 |
CN101163466B (zh) | 2011-12-07 |
ZA200707486B (en) | 2009-02-25 |
ATE524171T1 (de) | 2011-09-15 |
AU2006217650B2 (en) | 2011-06-09 |
GB0504103D0 (en) | 2005-04-06 |
DK1853241T3 (da) | 2012-01-16 |
PT1853241E (pt) | 2012-01-11 |
RU2007131934A (ru) | 2009-02-27 |
ES2374761T3 (es) | 2012-02-21 |
AU2006217650A1 (en) | 2006-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1094425A1 (en) | Substituted 2-aminotetralines for the preventive treatment of parkinson's disease | |
EP2400847A4 (fr) | Composés spécifiques de type diarylhydantoïne et diarylthiohydantoïne | |
MX2009006742A (es) | Inhibidores acilaminopirazoles como fgfr. | |
EP1940373B8 (fr) | 1-fluoro-1-deoxy-scyllo-inositol destine au traitement de la maladie d'alzheimer | |
TW200635582A (en) | Medicaments for the treatment or prevention of fibrotic diseases | |
GEP20115172B (en) | Bicyclic cinnamide compound | |
MY145439A (en) | Use of flibanserin for the treatment of pre-menopausal sexual desire disorders | |
TW200728307A (en) | Novel spirochromanone derivatives | |
GEP20115176B (en) | Prodrug of cinnamide compound | |
HK1152705A1 (en) | Dihydropyrimidine compounds and use thereof for the treatment of viral diseases | |
HK1110211A1 (fr) | ||
WO2009071690A3 (fr) | Dérivés d'oxindole à double substitution en positions 5 et 6 et leur utilisation pour traiter des maladies liées à la vasopressine | |
MX2008001546A (es) | 3,11b-cis-dihidrotetrabenazina para el tratamiento de una enfermedad proliferativa o una inflamacion. | |
WO2009025785A3 (fr) | Ligands de récepteur cb2 pour le traitement de la douleur | |
UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
DE602006010738D1 (de) | Pyrroloä2,3-cüpyridinderivate | |
TW200716547A (en) | Piperidin-4-yl-amide derivatives | |
TW200716152A (en) | Substituted 1,2-ethylendiamines, medicaments comprising said compound, their use and their method of manufacture | |
WO2007131907A3 (fr) | Dérivés de 1h-indol-5-yl-pipérazin-1-yl-méthanone | |
TW200635595A (en) | Medicaments for the treatment of prevention of fibrotic diseases | |
DK1670903T3 (da) | Behandling af neurodegenerative sygdomme | |
PT1778837E (pt) | Tratamento de doenças neurodegenerativas por utilização de inibidores de scd4 | |
WO2008057599A3 (fr) | Procédés de traitement de troubles associés à l'abeta et compositions | |
DE602007008947D1 (en) | 4,5,6,7-tetrahydrothienoä2,3-cüpyridine als h3-modulatoren | |
ZA200800999B (en) | Use of N-dibenz (b,f)oxepin-10-ylmethyl)-N-methyl-N-prop-2-ynylamine (omigapil) for the prophylaxis and/or treatment of muscular dystrophy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20160227 |